Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama

In this randomized, double-blinded Phase 2 trial, 30 patients with Leishmania panamensis cutaneous leishmaniasis were randomly allocated (1:1) to receive once daily topical treatment with WR 279,396 (15% paromomycin + 0.5% gentamicin) or Paromomycin Alone (15% paromomycin) for 20 days. The index les...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sosa, Néstor, Capitán, Zeuz, Nieto, Javier, Nieto, Melissa, Calzada, José, Paz, Hector, Spadafora, Carmenza, Kreishman-Deitrick, Mara, Kopydlowski, Karen, Ullman, Diane, McCarthy, William F., Ransom, Janet, Berman, Jonathan, Scott, Charles, Grogl, Max
Format: Artigo
Langue:Inglês
Publié: The American Society of Tropical Medicine and Hygiene 2013
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3771300/
https://ncbi.nlm.nih.gov/pubmed/23857024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.12-0736
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires